A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease

NCT05891496 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimers Disease

Interventions

DRUG: Semaglutide
DRUG: Placebo

Sponsor

Novo Nordisk A/S